Article Publish Status: FREE
Abstract Title:

Emodin rescued hyperhomocysteinemia-induced dementia and Alzheimer's disease-like features in rats.

Abstract Source:

Int J Neuropsychopharmacol. 2018 Nov 8. Epub 2018 Nov 8. PMID: 30407508

Abstract Author(s):

Peng Zeng, Yan Shi, Xiao-Ming Wang, Li Lin, Yan-Jun Du, Na Tang, Qun Wang, Ying-Yan Fang, Jian-Zhi Wang, Xin-Wen Zhou, Youming Lu, Qing Tian

Article Affiliation:

Peng Zeng


Background: Hyperhomocysteinemia (HHcy) is an independent risk factor for dementia, including Alzheimer's disease (AD). Lowering homocysteine levels with folic acid treatment with or without vitamin B12 was shown few clinical benefits on cognition.

Methods: To verify the effect of emodin, a naturally active compound from Rheum officinale, on HHcy-induced dementia, rats were treated with homocysteine injection (HCY, 400 g/kg/day, 2 weeks) via vena caudalis. Afterwards, HCY rats with cognitive deficits were administered intragastric emodin at different concentrations, namely, 0 (HCY-E0), 20 (HCY-E20), 40 (HCY-E40) and 80 mg/kg/day (HCY-E80) for 2 weeks.

Results: β-amyloid (Aβ) overproduction, tau hyperphosphorylation and losses of neuron and synaptic proteins were detected in the hippocampi of HCY-E0 rats with cognitive deficits. HCY-E40 and HCY-E80 rats had better behavioural performances. Although it did not reduce the plasma homocysteine level, emodin(especially 80 mg/kg/day) reduced the levels of Aβ and tau phosphorylation, decreased the levels of β-site amyloid precursor protein-cleaving enzyme 1, and improved the activity of protein phosphatase 2A. In the hippocampi of HCY-E40 and HCY-E80 rats, the neuron numbers, levels of synaptic proteins and phosphorylation of the cAMP responsive element-binding protein at Ser133 were increased; in addition, depressed microglial activation and reduced levels of 5-lipoxygenase, interleukin-6 and tumour necrosis factor α were also observed. Lastly, HHcy-induced microangiopathic alterations, oxidative stress and elevated DNA methyltransferases 1 and 3 were rescued by emodin.

Conclusions: Emodin represents a novel potential candidate agent for HHcy-induced dementia and AD-like features.

Study Type : Animal Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.